252
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Patient-Centered Communication for Discussing Oncotype DX Testing

, , , , , & show all
Pages 205-212 | Received 28 Nov 2015, Accepted 28 Mar 2016, Published online: 28 Apr 2016

References

  • Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25(33):5287–312. doi: 10.1200/JCO.2007.14.2364.
  • Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004;351(27):2817–26. doi: 10.1056/NEJMoa041588.
  • Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006;24(23):3726–34. doi: 10.1200/JCO.2005.04.7985.
  • Asad J, Jacobson AF, Estabrook A, Smith SR, Boolbol SK, Feldman SM, et al. Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? Am J Surg 2008;196(4):527–9. doi: doi:10.1016/j.amjsurg.2008.06.021.
  • Reed SD, Dinan MA, Schulman KA, Lyman GH. Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer. Genet Med 2013;15(3):203–11. doi: 10.1038/gim.2012.
  • Bombard Y, Rozmovits L, Trudeau M, Leighl NB, Deal K, Marshall DA. The value of personalizing medicine: medical oncologists' views on gene expression profiling in breast cancer treatment. Oncologist 2015;20(4):351–6. doi: 10.1634/theoncologist.2014-0268.
  • Richman AR, Tzeng JP, Carey LA, Retel VP, Brewer NT. Knowledge of genomic testing among early-stage breast cancer patients. Psychooncology 2011;20(1):28–35. doi: 10.1002/pon.1699.
  • McCormack LA, Treiman K, Rupert D, Williams-Piehota P, Nadler E, Arora NK, et al. Measuring patient-centered communication in cancer care: a literature review and the development of a systematic approach. Soc Sci Med 2011;72(7):1085–95. doi: 10.1016/j.socscimed.2011.01.020.
  • King N. Template analysis. In: Symon C, Cassell C, editors. Qualitative methods and analysis in organizational research: A practical guide. Thousand Oaks: Sage; 1998. 118–134.
  • Frambach R, Schillewaert N. Organizational innovation adoption: A multi-level framework of determinants and opportunities for future research. Journal of Business Research 2002(55):163–176. doi:10.1016/S0148-2963(00)00152-1.
  • Lillie SE, Brewer NT, O'Neill SC, Morrill EF, Dees EC, Carey LA, et al. Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy. Cancer Epidemiol Biomarkers Prev 2007;16(2):249–55. doi: 10.1158/1055-9965.EPI-06-0525.
  • Lipkus IM, Vadaparampil ST, Jacobsen PB, Miree CA. Knowledge about genomic recurrence risk testing among breast cancer survivors. J Cancer Educ 2011;26(4):664–9. doi: 10.1007/s13187-011-0248-5.
  • Carpenter WR, Meyer AM, Wu Y, Qaqish B, Sannoff HK, Goldberg RM, et al. Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation. Med Care 2012;50(8):737–48. doi: 10.1097/MLR.0b013e31824ebe13.
  • Brewer NT, Richman AR, DeFrank JT, Reyna VF, Carey LA. Improving communication of breast cancer recurrence risk. Breast Cancer Res Treat 2012;133(2):553–61. doi: 10.1007/s10549-011-1791-9. Epub 2011 Oct 1.
  • Leggett LE, Lorenzetti DL, Noseworthy T, Tiwana S, Mackean G, Clement F. Experiences and attitudes toward risk of recurrence testing in women with breast cancer: a systematic review. Breast Cancer Res Treat 2014. doi: 10.1007/s10549-014-2900-3.
  • Spiegel D. Psychological aspects of breast cancer treatment. Semin Oncol 1997; 24(S1):36–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.